Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Access Anti-HAV and Access Anti-HAV IgM Assays As an Aid in the Diagnosis of HAV Infection, and for Detection of Anti-HAV After Vaccination: EU Clinical Trial Protocol

NCT06289868 is registered in ClinicalTrials.gov with Beckman Coulter, Inc. as lead sponsor.

NCT NCT06289868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06289868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Access Anti-HAV and Access Anti-HAV IgM Assays As an Aid in the Diagnosis of HAV Infection, and for Detection of Anti-HAV After Vaccination: EU Clinical Trial Protocol
Lead sponsor
Beckman Coulter, Inc.
Phase
Observational
Overall status
Completed
Start date
February 27, 2024
Completion date
August 29, 2024
Enrollment
1,409 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hav